We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$526M
AUM Growth
-$50.4M
Cap. Flow
-$82.9M
Cap. Flow %
-15.78%
Top 10 Hldgs %
49.03%
Holding
65
New
2
Increased
16
Reduced
32
Closed
1

Top Buys

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$8.58M
2
WBA
Walgreens Boots Alliance
WBA
+$8.29M
3
PEP icon
PepsiCo
PEP
+$3.74M
4
GNTX icon
Gentex
GNTX
+$3.16M
5
KOF icon
Coca-Cola Femsa
KOF
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 30.89%
2 Technology 19.35%
3 Industrials 15.78%
4 Financials 12.84%
5 Consumer Staples 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$117B
$38.3M 7.28%
473,783
-89,937
-16% -$7.2M
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
$34.6M 6.58%
476,425
+117,631
+33% +$8.29M
JNJ icon
3
Johnson & Johnson
JNJ
$646B
$31.5M 5.99%
225,276
-185,499
-45% -$25.8M
MSFT icon
4
Microsoft
MSFT
$3.81T
$28.1M 5.35%
328,508
-68,705
-17% -$5.64M
ORCL icon
5
Oracle
ORCL
$435B
$23.7M 4.51%
501,831
-35,335
-7% -$1.73M
RTX icon
6
RTX Corp
RTX
$285B
$21M 4%
261,972
-5,597
-2% -$425K
PEP icon
7
PepsiCo
PEP
$193B
$20.8M 3.96%
173,461
+32,764
+23% +$3.74M
UNP icon
8
Union Pacific
UNP
$183B
$20.7M 3.93%
154,230
-8,557
-5% -$1.03M
AXP icon
9
American Express
AXP
$225B
$20.2M 3.84%
203,153
-26,320
-11% -$2.51M
AON icon
10
Aon
AON
$75.4B
$18.9M 3.6%
141,298
-49,304
-26% -$7.02M
CSCO icon
11
Cisco
CSCO
$433B
$17.2M 3.26%
447,991
+33,261
+8% +$1.19M
WFC icon
12
Wells Fargo
WFC
$262B
$16.1M 3.06%
265,058
-131,120
-33% -$7.41M
GNTX icon
13
Gentex
GNTX
$4.78B
$16M 3.05%
764,279
+158,778
+26% +$3.16M
MSI icon
14
Motorola Solutions
MSI
$80.4B
$15.3M 2.91%
169,199
-23,775
-12% -$2.17M
BAX icon
15
Baxter International
BAX
$13.5B
$12.5M 2.37%
193,084
-5,720
-3% -$367K
UNH icon
16
UnitedHealth
UNH
$353B
$12.4M 2.36%
56,371
-90,341
-62% -$19.1M
PFE icon
17
Pfizer
PFE
$159B
$11.6M 2.21%
338,764
+10,968
+3% +$374K
JCI icon
18
Johnson Controls International
JCI
$84.6B
$9.64M 1.83%
252,996
+7,272
+3% +$284K
TFC icon
19
Truist Financial
TFC
$61.6B
$8.84M 1.68%
+177,763
New +$8.58M
GWW icon
20
W.W. Grainger
GWW
$61.5B
$8.52M 1.62%
36,058
-14,806
-29% -$3.06M
CHRW icon
21
C.H. Robinson
CHRW
$17.6B
$7.84M 1.49%
88,050
+1,839
+2% +$150K
NVS icon
22
Novartis
NVS
$292B
$7.12M 1.35%
94,665
-92,514
-49% -$6.98M
BTI icon
23
British American Tobacco
BTI
$121B
$6.74M 1.28%
100,661
+18,716
+23% +$1.22M
CHKP icon
24
Check Point Software Technologies
CHKP
$14.1B
$6.67M 1.27%
64,327
-36,213
-36% -$3.93M
SABR icon
25
Sabre
SABR
$888M
$6.65M 1.27%
324,590
+49,675
+18% +$951K

Similar funds

Foyston, Gordon, & Payne's Q4 2017 Portfolio in Review

As of Q4 2017, Foyston, Gordon, & Payne held 65 positions worth $526M, down 8.7% from $576M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $82.9M in Q4 2017, closing 1 position and reducing 32 holdings. Its most notable exit was Outfront Media, an estimated $2.82M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Truist Financial worth $8.84M.

  • Foyston, Gordon, & Payne's largest Q4 2017 buy was Truist Financial: 177,763 shares worth $8.84M.
  • Foyston, Gordon, & Payne added most to Walgreens Boots Alliance in Q4 2017, an estimated $8.29M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $25.8M.
  • Foyston, Gordon, & Payne fully exited Outfront Media in Q4 2017, selling an estimated $2.82M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 49% of its $526M portfolio in Q4 2017.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 1 in Q4 2017.
  • Foyston, Gordon, & Payne's portfolio value fell 8.7% quarter-over-quarter to $526M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2017, filed 14 Feb 2018.